EPL launches Orofer FCM 750, containing Ferric carboxymaltose. Orofer FCM is a new dosage variant designed to provide a more effective and convenient option for patients with iron deficiency and IDA. Orofer FCM 750mg/15ml is available for the treatment of patients with hemoglobin less than 10 g/dl and body weight between 35 kg to 70kg.
The operational guidelines for the “Anemia Mukt Bharat” Programme recommended FCM as the first-line treatment for severe and selected cases of mild-to-moderate anemia in pregnant women in India. IDA is a significant burden for women, especially during later trimesters and due to postpartum hemorrhage (PPH). Indian studies have indicated that most patients need FCM 1500 mg at body weight between 35-70 kgs. A single dose of FCM up to 750 mg of iron can be infused in a short time frame of 15 minutes diluted in 250 ml of normal saline.
Anil Kothiyal, President of India Business at Emcure Pharmaceuticals said “At Emcure Pharmaceuticals, we recognize IDA as a major public health concern in India, particularly among women. We feel satisfied to introduce Orofer FCM 750 to help address this significant burden of IDA in India.”
